Key result
Chronic kidney disease was associated with lower flow-mediated dilatation compared to controls, which improved to 15.7% three months after renal transplantation.
Why the study?
Does renal transplantation improve endothelial dysfunction in patients with chronic kidney disease?
Observational (n=108)
Does renal transplantation improve endothelial dysfunction in patients with chronic kidney disease?
Renal transplantation significantly improves endothelium-dependent vasodilation in patients with chronic kidney disease within three months.
Answers are grounded in this paper and cite their sources.
Endothelial dysfunction assessment may refine CV risk stratification in CKD; leaves open whether transplantation restores function.
BACKGROUND: Endothelial dysfunction may explain increased cardiovascular risk in patients with chronic kidney disease (CKD). METHODS: Brachial artery was imaged during reactive hyperemia (endothelium-dependent, flow-mediated dilatation, FMD) and during glyceryl trinitrate-mediated dilatation (nitroglycerine-mediated dilatation, NMD, endothelium-independent) in 108 patients with CKD and three months following renal transplantation (RT) in 60 of them. RESULTS: Patients with CKD had significantly lower FMD vs. controls (9.1% vs. 18.3%, p < 0.001) while NMD was comparable (19.8% vs. 21.8%, p = ns). Impaired FMD (<4.5%) was observed in 26.8% patients with CKD and was more common in those on hemodialysis (HD; 28.4% vs. 15.4%) vs. those not on dialysis. FMD for patients with glomerular filtration rate (GFR) 15-60 vs. <15 mL/min/1.73 m(2) was 12.9% and 8.8% (p = 0.05; respectively -29% and -52% lower vs. controls), indicating reduced FMD with increasing CKD severity. There was +72% increase in FMD following RT (9.1 to 15.7%, p < 0.001) while mean NMD was unchanged. Following RT, only 3.3% had impaired FMD. CONCLUSIONS: Patients with CKD have endothelial dysfunction as evidenced by reduced FMD. Decreased FMD indicating worsening endothelial function was noted with increasing severity of CKD. Within three months of RT, there was significant improvement in FMD, while NMD values did not change.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2014) conducted an observational in Chronic kidney disease (n=108). Chronic kidney disease vs. Healthy controls was evaluated on Flow-mediated dilatation (FMD) (p=<0.001). Chronic kidney disease was associated with lower flow-mediated dilatation compared to controls, which improved to 15.7% three months after renal transplantation.
Synapse has enriched 10 related papers. Consider them for comparative context: